본문바로가기
About Us
SK bioscience
Company Overview
History
Vision
Contact Us
Leadership
Message from the CEO
Headquarters & Facilities
SK bioscience Headquarters
R&D Center
L HOUSE
Subsidiary
SK bioscience USA
IDT Biologika
Science & Technology
Pipeline
R&D
Production
Business
Business Overview
Domestic
Overseas Business
Vaccine Co-Development
and Technology Transfer
CDMO/CMO
Products
In-house Products
Outsourced Products
Global Partnerships
ESG
새창열기 아이콘
IR
Corporate Governance
Company Information
Financial Information
Financial Statements
Financial Credit
Audit Reports
Investment Information
Stock Prices
Shareholder Status
IR Documents
Disclosure
PR
Press Releases
Media Zoom
Brochure
CI Guideline
sitemap
About Us
SK bioscience
Company Overview
History
Vision
Contact Us
Leadership
Message from the CEO
Headquarters & Facilities
SK bioscience Headquarters
R&D Center
L HOUSE
Subsidiary
SK bioscience USA
IDT Biologika
Science & Technology
Pipeline
R&D
Production
Business
Business Overview
Domestic
Overseas Business
Vaccine Co-Development
and Technology Transfer
CDMO/CMO
Products
In-house Products
Outsourced Products
Global Partnerships
ESG
IR
Corporate Governance
Company Information
Financial Information
Financial Statements
Financial Credit
Audit Reports
Investment Information
Stock Prices
Shareholder Status
IR Documents
Disclosure
PR
Press Releases
Media Zoom
Brochure
CI Guideline
사이트맵 닫기
Language
KOR
ENG
LinkedIn
YouTube
ESG
SK careers
C/S
SK ethics
Q
U
I
C
K
PR
SK bioscience company news updates
PR
About Us
Science & Technology
Business
ESG
IR
PR
Press Releases
Press Releases
Media Zoom
Brochure
CI Guideline
Press releases
SK bioscience and Hilleman Laboratories to Co-develop New Vaccine Platforms
2022.10.27
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
2022.10.25
SK bioscience Appoints New Executives towards Global Business Growth
2022.10.21
SK bioscience Submits Emergency Use Listing (EUL) of SKYCovione™ to the World Health Organization
2022.09.08
SK bioscience Begins First Shipment of Korean COVID-19 Vaccine
2022.09.02
SK-Bill & Melinda Gates Foundation met to discuss shared commitments to global health
2022.08.16
SK bioscience Announces Adolescent Authorization of Protein Based COVID-19 Vaccine, Nuvaxovid
2022.08.12
SK bioscience Submits Application for Conditional Marketing Authorization of COVID-19 Vaccine, SKYCovion™ to European Medicines Agency
2022.08.01
SK bioscience Submits Conditional Marketing Authorization Application of COVID-19 Vaccine, SKYCovion™ to the Medicines and Healthcare Products Regulatory Agency
2022.07.29
SK bioscience Announces Agreement with Novavax to Manufacture COVID-19 Vaccine Containing Omicron Variant
2022.07.19
처음
이전
1
2
3
4
5
6
7
8
9
10
다음
끝
